[This review was originally posted at the Nieman Journalism Lab Synthroid Over The Counter, on Dec. 16, 2011.]

Sides line up on SOPA: The Stop Online Piracy Act, or SOPA, continues to make its way through Congress, earning derision from all corners of the web at every step of the way. Order Synthroid online overnight delivery no prescription, This week, a House hearing was held on a new version of the bill was amended to allow Internet service providers to choose the "least burdensome" means of preventing access to websites, rather than explicitly requiring them to block domain names. As Techdirt's Mike Masnick explained, it also contains several other changes to bring it more into line with the Senate version of the bill, though it's still a censorship bill. Julian Sanchez of the Technology Liberation Front made a similar argument: "There is no “right” way to do Internet censorship, purchase Synthroid online no prescription, and the best version of a bad idea remains a bad idea."

Meanwhile, the bill's supporters and detractors seem to be organizing along predictable lines: Many of the largest media companies in the world, like Disney, News Corp., Viacom, Where can i buy Synthroid online, and Time Warner, voiced their support for the bill. Of course, they're also maintaining that they're "pro-Internet" as they do this, as the film industry's Chris Dodd declared, Synthroid Over The Counter. Journalists — most recently the American Society of News Editors — have been lining up against the bill, and top constitutional law scholar Laurence Tribe made the case against the bill as well.

Wikipedia has been considering imposing a brief blackout on itself, and its attorney, Geoff Brigham, no prescription Synthroid online, laid out the site's legal argument against the bill. A bunch of stars from the tech start-up world launched a site called I Work for the Internet highlighting the economic threat SOPA poses, which was immediately mocked by Gawker.

There's also an international angle to this: Global Voices' Ivan Sigal and Rebecca MacKinnon pointed out the potential global censorship threats of the bill. Synthroid Over The Counter, And it's also worth noting that a SOPA alternative (called OPEN) has been introduced in the House, which, as Mathew Ingram of GigaOM noted, has been received a bit more warmly by some SOPA critics.

—

A social model for news: One of the web's top political bloggers, Synthroid dose, Politico's Ben Smith, announced this week he was leaving to take the editor-in-chief job for an unlikely employer: BuzzFeed, an aggregator of what's viral on the web. As Smith and BuzzFeed CEO Jonah Peretti (a co-founder of the Huffington Post) told the Atlantic Wire and Fast Company, their goal is to make their site the first to organize itself around its social distribution model at its core, incorporating the talk on the web around issues into each story and building content fundamentally to be shared. GigaOM's Mathew Ingram noted that this distribution-oriented model is the opposite of the one employed by most traditional news orgs and advised to observe its fate closely, after Synthroid.

Smith and Peretti see it as the next iteration of the SEO-focused approach pioneered by the Huffington Post and currently followed by many others, and Smith told Fast Company he saw it as an improvement: "A lot of online journalism has been about gaming search engine algorithms — writing, in a way, for machines. Sharing is fundamentally about producing things people like."

Smith also told the Lab's Megan Garber he and his staff would still be doing old-fashioned political reporting, and Reuters' Jack Shafer looked at another viral aggregator, Fark, to find out why adding journalism to that mix could be a good idea, Synthroid Over The Counter.

—

Twitter's play for the casual user: One issue to catch up on from late last week: Twitter unveiled a redesign that orients the site around four new tabs: Home, Synthroid no rx, Connect, Discover, and Me. In a critical review, John Gruber of Daring Fireball explained how the new interface works, but also worried about what the changes mean for where Twitter is headed: "The Twitter service this new UI presents is about ... mass-market spoonfed 'trending topics' and sponsored content, order Synthroid no prescription. It’s trying to make Twitter work for people who don’t see the appeal of what Twitter was supposed to be."

Gruber wasn't the only who looked at the new Twitter and saw a grab for traffic and advertisers. ZDNet's Larry Dignan said Synthroid Over The Counter, it's about keeping users on longer and feeding ad revenue, and Gizmodo's Casey Chan called it "Twitter for the lurkers." The New York Times' Nick Bilton explained further how Twitter is trying to make itself simpler for non-techies, and as Ad Age reported, this redesign also includes the addition of brand pages for companies and marketers.

New ReadWriteWeb editor Dan Frommer also had some good takeaways from the redesign: Search and lists are being de-emphasized, and Twitter is trying to scale up to get really, really big. On the latter point, Synthroid treatment, Mashable's Sarah Kessler pointed out several ways in which Twitter is going after Facebook with these changes. As far as news goes, Poynter's Jeff Sonderman saw a lot of potential for driving traffic and discovering news through the new Discover tab.

—

Classifying journalism by "what," not "who": As much as we complain about it, it turns out we were apparently eager to take another opportunity to argue about the "bloggers vs. journalists" issue, Synthroid Over The Counter. Discussion continued this week about the Oregon court ruling, Synthroid results, reported last week, that declared that a blogger was not entitled to the same legal protections as journalists.

The New York Times' David Carr echoed some of skepticism summarized here last week about whether the blogger in question was really acting as a journalist or more of an online antagonist. Others maintained that this blogger's particular behavior was irrelevant to the larger legal question at hand: Boston j-prof Mark Leccese worried that this ruling could become an important precedent, though Eric Robinson of the Citizen Media Law Project pointed out that there are other legal precedents classifying bloggers as journalists. Herbal Synthroid, John Dvorak of PC Magazine ripped the decision apart, and the New York Times brought several people together to consider whether and how the courts should consider bloggers to be journalists. The Atlantic's Rebecca Rosen threw some (needed) cold water on the entire argument over who's a journalist by contending Synthroid Over The Counter, that the notion of press freedom as protecting journalists is an anachronism, as the idea of a professional journalist didn't exist when the First Amendment was written. Instead of focusing on the "who," she said, comprar en línea Synthroid, comprar Synthroid baratos, we should look at the "what" — the quality and content of information for the good of the public and democracy, rather than who's producing it.

—

Reading roundup: There wasn't any dominant story this week, but it was a pretty busy one overall. Here's what else you might have missed:

— Mark Hemingway of the conservative magazine The Weekly Standard issued a critique of journalistic fact-checking operations, Synthroid blogs, calling them an attempt by liberal news orgs to impose some authority on political discourse. Forbes' John McQuaid agreed that fact-checking is indeed flawed, but not in the way Hemingway described — he called for more reporting and less unmerited certainty. Meanwhile, Ethan Zuckerman reported on a talk on the rise of fact-checking by a Columbia grad student, Synthroid Over The Counter.

— There are new holes being poked in News Corp.'s phone hacking defense every week, but this could be a particularly big one: We found out that James Murdoch replied to an email referring to the hacking as a major problem in 2008, long before he's said he knew about the breadth of the issue. The New York Times' David Carr wondered when James Murdoch's house of cards will fall, Synthroid price, coupon, and another former News of the World editor was arrested in the scandal.

— A USC study predicted that most newspapers (all but the smallest and largest) will be dead in five years. Longtime newspaper editor John Robinson was dubious.

— Free Press' Josh Stearns commented on another USC study on open journalism to argue for journalism as a service, rather than a product. Synthroid class, O'Reilly Media's Alex Howard reported on a talk given by the scholar who wrote that study, Melanie Sill, and Lab contributor Nikki Usher about what open-source culture can teach journalism.

— Media consultant Judy Sims gave newspaper executives two ways to think radically differently, one of which hasn't been discussed much: Jealously defending their talent, giving them more control over and equity in the products they're developing.

Similar posts: Armour Price. Cipro No Rx. Buy Flagyl No Prescription. Diflucan results. Diflucan alternatives. Doses Zoloft work.
Trackbacks from: Synthroid Over The Counter. Synthroid Over The Counter. Synthroid Over The Counter. Online buying Synthroid hcl. Purchase Synthroid for sale. Synthroid coupon.

[This review was originally posted at the Nieman Journalism Lab Glucophage For Sale, on Dec. 9, 2011.]

Do institutions have a place in news innovation?: About three weeks after Dean Starkman's indictment of future-of-news thinkers was posted online by the Columbia Journalism Review, NYU professor Clay Shirky — one of the primary targets of the piece — delivered a response late last week in the form of a thoughtful essay on the nature of institutions and the news industry. Shirky explained the process by which institutions can lapse into rigidity and blindness to their threats, and he argued that there's no way to preserve newspapers' most important institutional qualities in the digital age, buy Glucophage from mexico, so the only option left is radical innovation.

Several observers — of a future-of-news orientation themselves — jumped in to echo Shirky's point. The Journal Register Co.'s Steve Buttry praised Shirky for waiting and reflecting rather than responding immediately, and media consultant Steve Yelvington seconded Shirky's point that all this talk about traditional journalistic models being overwhelmed by a decentralized, Effects of Glucophage, audience-focused digital tidal wave is descriptive, not prescriptive — not necessarily the way things should be, but simply the way they are.

Howard Owens of the Batavian took the middle ground, declaring that evolution, not revolution, is the standard vehicle for change in journalism and laying a model for sustainable local journalism that focuses on local ownership, startups, and innovation, Glucophage For Sale. In the end, Owens wrote, online journalism will evolve and survive. "It will find ways to make more and more money to pay for more and more journalism.  The audience is there for it, Glucophage wiki, local businesses will always want to connect with that audience, and entrepreneurial minded people will find ways to put the pieces together."

The Atlantic's Alexis Madrigal raised a good point in the discussion about how to preserve serious journalism: He argued that the primary obstacle won't be so much about paying for journalists to cover important public-affairs issues, but about finding a way for that news to reach a substantial percentage of the population in a given area. That "amplification" problem may be tough to solve, Fast shipping Glucophage, but could be relatively easy to scale once that initial solution is found.

—

Paywalls picking up steam among smaller papers: Now that the New York Times has bravely served as a paywall guinea pig for the rest of America's newspapers (apparently successfully, judging from the indicators we have so far), we're starting to see more of the nation's mid-sized papers announce online pay plans of their own. This week, Gannett, Glucophage used for, the U.S.' largest newspaper chain, revealed that it would be expanding its paywalls to more of its papers sometime next year. According to the Gannett Blog Glucophage For Sale, , the company began experimenting with paywalls at three newspapers last year, and while we don't know much of anything about those projects, it appears Gannett is pleased enough with them to build out on that model.

The Chicago Sun-Times also announced a paywall to begin this week: It'll follow the increasingly popular metered model employed by the Financial Times and New York Times, allowing 20 page views per 30-day period before asking for $6.99 a month ($1.99 for print subscribers). Buy generic Glucophage, PaidContent noted that the plan is being run by Press+ (the system created by Steve Brill's former Journalism Online) and that Roger Ebert has been exempted from the paywall.

We also got a couple of updates from existing newspaper paywalls: MinnPost reported that the Minneapolis Star Tribune has come out ahead so far in its new paywall, generating an estimated $800,000 in subscriptions while losing a five-figure total of advertising dollars. And PaidContent reported that three paywalled MediaNews Group papers (now run by John Paton of the Journal Register Co.) have killed their Monday print editions, with a corresponding drop of their online paywall on those days, Glucophage samples.

—

Is this blogger a journalist?: Just when you thought the "Are bloggers journalists?" discussion was completely played out, it got some new life this week when an Oregon judge ruled that a blogger being sued for $2.5 million in a defamation case wasn't protected by the state's media shield law because she wasn't a journalist, Glucophage For Sale. As Seattle Weekly initially reported, the judge reasoned that she wasn't a journalist because she wasn't affiliated with any "newspaper, magazine, periodical, What is Glucophage, book, pamphlet, news service, wire service, news or feature syndicate, broadcast station or network, online Glucophage without a prescription, or cable television system."

This type of ruling typically gets bloggers (and a lot of journalists) riled up, and rightly so. Mathew Ingram of GigaOM gave some great context regarding state-by-state shield laws, noting that several other recent rulings have defined who's a journalist much more broadly than this judge did. Online buying Glucophage, These types of distinctions based on institutional affiliation are attempts to hold back a steadily rising tide, he argued.

On the other hand, Forbes' Kashmir Hill described some of the case's background that seemed to indicate that this particular blogger was much more intent on defamation than performing journalism, creating dozens of sites to dominate the search results for the company she was attacking, then emailing the company to offer $2, Glucophage australia, uk, us, usa,500/mo. Glucophage For Sale, online reputation management. Hill concluded, "Yes, bloggers are journalists. Glucophage dosage, But just because you have a blog doesn’t mean that what you do is journalism." Libertarian writer Julian Sanchez agreed, saying that while the judge's ruling wasn't well worded, this blogger was not a journalist.

—

Facebook's new tools: A few Facebook-related notes: The social network began rolling out Timeline, the graphical life-illustration feature it announced back in September this week, starting in New Zealand, Glucophage cost. It also briefly, vaguely announced plans to extend its Twitter-like Subscribe button into a plugin for websites, a move that TechCrunch said signifies that "the company is directly attacking the entire Twitter model head-on." Cory Bergman of Lost Remote urged news orgs to get on the Subscribe bandwagon as soon as they can, as a way to extend their journalists' brands.

Meanwhile, news business consultant Alan Mutter laid out a basic plan for publishers to not just gain audience on Facebook, but make money there, too, Glucophage For Sale. Glucophage pics, The key element of that plan may be a surprising one: "The most intriguing and perhaps most productive approach for making money off Facebook, however, is for newspapers to take over the social media marketing and advertising campaigns for businesses in their markets."

—

Reading roundup: Pretty slow week this week, but there were a few smaller stories worth keeping an eye on:

— As a sort of sequel to the Huffington Post's OffTheBus effort in the 2008 U.S. presidential campaign, Jay Rosen and NYU's Studio 20 are partnering with the Guardian to determine and cover "the citizens' agenda" in the 2012 election, Glucophage brand name. Rosen and NYU will also be working with MediaNews and the Journal Register Co. on the local and regional level. Glucophage For Sale, At the Lab, Megan Garber explained what's behind the initiative.

— The American Journalism Review published a piece on the journalistic ethics of retweeting that included news that the Oregonian is telling its reporters to consider all retweets as endorsements. The Journal Register Co.'s Steve Buttry rounded up (appalled) reaction and argued that editors should consider each case individually.

— Ten NBC-owned TV stations in Chicago, Philadelphia, and Los Angeles will work with nonprofit news orgs (public radio in LA and Philly, and the Chicago Reporter and ProPublica) in a new initiative first reported by the LA Times.

— The popular iPad news aggregation app Flipboard launched for iPhone this week, and Poynter's Jeff Sonderman drew lessons on mobile design for news orgs from it.

— The New York Times reported that most of the pack of would-be iPad competitors in the tablet market have fizzled out, though the Kindle Fire and Nook Tablet have gotten off to promising starts.

— Here at the Lab, longtime newspaper editor Tom Stites is in the midst of an interesting three-part series on the state of web journalism. Part one is a good overview of where we are and where we want to go, and part two looks at the wide-ranging effects of layoffs and cuts into local journalism.

Similar posts: Diflucan Over The Counter. Retin A Dosage. Purchase Zoloft. Discount Cephalexin. Canada, mexico, india. Zoloft used for.
Trackbacks from: Glucophage For Sale. Glucophage For Sale. Glucophage For Sale. Where can i buy cheapest Glucophage online. Buy Glucophage without a prescription. Buy generic Glucophage.